Gem & Jewellery Sector Targets $100B Exports by 2047
India's gem and jewellery industry is poised to achieve a $100 billion export milestone by 2047, reducing reliance on traditional markets. Read the full story.
Category : Search result: USD 500 billion pharma sector
Nvidia CEO: $500B AI Demand Outlook Firm, Upside Ahead
Nvidia CEO Jensen Huang confirms the firm's $500 billion AI demand visibility for 2025-26 won't be revised quarterly, with CFO noting it has already grown. Details from CES 2026.
EMS, Telecom, Retail Sectors Set for Strong 2-Year Growth
A new report forecasts robust earnings growth for India's EMS, telecom, and retail sectors over the next two years, driven by domestic demand and strategic investments. Read the full analysis.
US Markets Close 2025 Higher Despite Final Session Loss
Wall Street's major indexes fell slightly on the last trading day of 2025 but are set for strong double-digit yearly gains, fueled by AI stocks. Nike and Vanda Pharma saw notable moves.
UHSR Rohtak Declares 2025 Exam Results: Download PDFs
Pandit Bhagwat Dayal Sharma University of Health Sciences, Rohtak has published results for B.Pharmacy, GNM, and M.Pharma exams. Download official gazettes from uhsr.ac.in.
Reliance Denies $30 Billion Government Claim Reports
Reliance Industries strongly denies media reports claiming a $30 billion demand from the Indian government, calling them baseless and irresponsible. Get the full facts here.
6 Arrested in Varanasi Codeine Cough Syrup Racket
Varanasi and Mirzapur police crack down on a major codeine-based cough syrup smuggling ring, arresting six. The network used shell firms and hawala to supply syrup to Bangladesh at 10x price.
Sigachi MD Arrested Over Hyderabad Pharma Blast
Telangana police arrest Sigachi MD Amit Raj Sinha for negligence in June 30 blast that killed 54 workers. Case highlights safety failures in hazardous units. Read the full investigation details.
Govt Mulls 1-Year Extension for Pharma GMP Norms
The Indian government considers a one-year extension for MSMEs to comply with revised Schedule M GMP norms, aiming to prevent plant closures and safeguard its $50 billion pharma sector. Read more.
Ajanta Pharma's Semaglutide Deal Boosts Growth Prospects
Ajanta Pharma partners with Biocon to market weight-loss drug semaglutide in 26 markets. Deal expected to add ₹200 crore sales by FY28, enhancing its branded generics focus. Read more.
Obesity Drug Market in India Grows 10-Fold in 5 Years
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
Orange Biotech PCD Pharma Franchise: Lucrative Business Opportunity
Orange Biotech Private Limited unveils a nationwide PCD pharma franchise with high-profit margins, monopoly rights, and extensive product portfolio for entrepreneurs. Start your own pharma business today!
Aurobindo Pharma increases stake in China JV to 50%
Aurobindo Pharma's Dutch arm buys 20% more in China's Luoxin Aurovitas for $5M, aiming for 100% ownership by 2029 to scale up inhalation product manufacturing. Read the full strategic move.
Ajanta Pharma & Biocon Partner for Generic Weight Loss Drug
Ajanta Pharma partners with Biocon to distribute generic semaglutide in 26 Asian and African markets. The move targets the booming GLP-1 market post-patent expiry, leveraging Ajanta's strong distribution network.
JioHotstar Series Questions India's Pharmaceutical System
JioHotstar's new series 'Pharma' ignites public debate on drug pricing, ethics, and accessibility in India's healthcare system. Read the full analysis.
India Pharma Targets $500B, Innovation Hub by 2047
India's pharmaceutical industry gears up for a critical 5-year phase from 2026, aiming to become a $500 billion innovation hub by 2047. Learn how it plans to tackle challenges and seize opportunities.
UST & IIT Madras Partner to Nurture Deep-Tech Healthcare Startups
UST and IIT Madras Incubation Cell sign MoU to accelerate healthcare startups. 'Pitch to Win: Pharma 4.0' challenge sees 90+ entries. Winners get funding up to Rs 45 lakh. Read more.
Sonipat Trader Held in Rs 118 Cr GST Evasion Case
CGST Rohtak arrests Sonipat pharma trader Pawel Garg for alleged GST evasion of Rs 21.30 crore on sales of Rs 118.49 crore. Raid uncovers unaccounted transactions. Read the full details.
Rajit Kapur's Malayalam comeback after 25 years
National Award-winning actor Rajit Kapur discusses his return to Malayalam cinema with the medical drama 'Pharma', his role as Dr. Rajiv Rao, and the rise of South Indian OTT content.
Bangladesh Beats India to Export Weight-Loss Drugs to Emerging Markets
Bangladesh's pharma firms have a 2-year head start over Indian giants like Dr Reddy's in exporting generic semaglutide. Delhi HC allows exports, but domestic sales wait until 2026. Explore the competitive landscape.
Nivin Pauly's 'Pharma' Web Series Review: A Must-Watch Thriller
Nivin Pauly's 'Pharma', Malayalam's first medical drama web series, is now streaming. Our review explores its gripping plot, stellar cast, and why it's a binge-worthy thriller. Watch now!
Sun Pharma Shares Fall 3% Post-US FDA Inspection
Sun Pharmaceutical shares fell over 3% after a US FDA inspection at its Baska plant. The inspection concluded with 3 observations. Get the full details on the market impact and company's response.
Nivin Pauly's Pharma Web Series Premieres Dec 19 on JioHotstar
Malayalam star Nivin Pauly headlines 'Pharma', a hard-hitting web series on the dark side of the pharmaceutical industry. Premieres December 19, 2025, on JioHotstar in 5 languages.
Odisha Pharma Summit 2025 garners Rs 7,043 crore proposals
Odisha CM Mohan Majhi positions state as top pharma & medical devices investment destination. New policy & parks attract Rs 7,043 crore proposals, 45 MoUs signed. Read more.
Odisha Pharma Policy 2025 Launch: CM Majhi Unveils Strategy
Odisha CM Mohan Charan Majhi launches the Pharmaceutical and Medical Devices Policy 2025, aiming to attract investments and create jobs. The state announces two dedicated industrial parks. Read more.
Corona Remedies IPO Opens: Key Details & Strong GMP
Corona Remedies IPO subscription starts Dec 8. Price band ₹1008-1062, aims to raise ₹655 cr. Grey market premium signals strong investor interest. Details inside.
Corona Remedies IPO Subscription Begins, GMP at ₹290
Corona Remedies' ₹655 crore IPO opens today. With a price band of ₹1,008-₹1,062 and a strong GMP, analysts give a 'Subscribe for long term' rating. Key dates and details inside.
Odisha Approves Pharma & Medtech Policy 2025
Odisha's new Pharma & Medtech Policy 2025 aims to make the state a strategic hub for healthcare manufacturing. The policy includes plans for dedicated industrial parks and a roadmap aligned with India's 2047 vision. Read more.
Himachal Pharma Sector Faces Major Trust Crisis
Himachal Pradesh's pharmaceutical hub is in turmoil as 38 firms lose WHO-GMP certification, raising serious quality concerns. Discover the causes and impact.
Nivin Pauly's 'Pharma' Trailer Targets Unethical Drug Practices
Nivin Pauly's OTT debut 'Pharma' trailer reveals a medical rep exposing dangerous drugs. The series premieres on JioCinema December 19 in 7 languages. Read more.
Page 1 of 4